Bipolar disorder has one of the strongest genetic signals in psychiatry: first-degree relatives of someone with bipolar disorder have roughly a 10-fold increased risk compared with the general population. Heritability estimates run from 60 to 85 percent, which points to biology rather than personal weakness or upbringing as the primary driver.
At the neurochemical level, bipolar disorder involves dysregulation across multiple neurotransmitter systems including dopamine, serotonin, norepinephrine, and glutamate. During manic episodes, dopaminergic and noradrenergic signaling tends to be excessive, while depressive episodes involve reduced monoamine activity and altered glutamate function. Accurate bipolar diagnosis management is essential because medications that work for unipolar depression can destabilize mood in bipolar disorder.
Brain imaging studies show structural and functional differences in the prefrontal cortex, amygdala, and anterior cingulate, regions that regulate emotion, impulse control, and reward. Environmental triggers such as sleep disruption, substance use, major life stress, and seasonal changes interact with this underlying biology to precipitate episodes, which is why consistent medication management for bipolar combined with lifestyle structure produces the most reliable stability.
